SCHEMBL14714110

SCHEMBL14714110

CC(C)C[C@@H](CO)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@H](O)C1O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ADORA3 P0DMS8 3/20 0.67
▸ ADORA2A P29274 3/20 0.67
▸ ADORA1 P30542 2/20 0.67
▸ TP53 P04637 1/20 0.67
▸ CYP3A4 P08684 1/20 0.67
▸ TSHR P16473 1/20 0.67
▸ ALOX12 P18054 1/20 0.67
▸ NFKB1 P19838 1/20 0.67
▸ HIF1A Q16665 1/20 0.67
▸ ALDH1A1 P00352 1/20 0.67
▸ HPGD P15428 1/20 0.67
▸ PMP22 Q01453 1/20 0.67
▸ NPC1 O15118 1/20 0.67
▸ ADORA2B P29275 1/20 0.67
▸ RAB9A P51151 1/20 0.67
▸ RXFP1 Q9HBX9 1/20 0.67
▸ SLC6A2 P23975 1/20 0.66
▸ SLC6A3 Q01959 1/20 0.66

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20626493 1.00 ADORA3 (0.67) ADORA3ADORA2AADORA1TP53CYP3A4
SCHEMBL20626492 1.00 ADORA3 (0.67) ADORA3ADORA2AADORA1TP53CYP3A4
SCHEMBL14713414 1.00 ADORA3 (0.67) ADORA3ADORA2AADORA1TP53CYP3A4
SCHEMBL20626351 0.92 ADORA3 (0.73) ADORA3ADORA2AADORA1TP53CYP3A4
SCHEMBL20626353 0.92 ADORA3 (0.73) ADORA3ADORA2AADORA1TP53CYP3A4
SCHEMBL14713426 0.92 ADORA3 (0.73) ADORA3ADORA2AADORA1TP53CYP3A4
SCHEMBL14714117 0.92 ADORA3 (0.73) ADORA3ADORA2AADORA1TP53CYP3A4
SCHEMBL20626277 0.88 SLC29A1 (0.67) ADORA3ADORA2AADORA1TP53CYP3A4
SCHEMBL9793258 0.88 ADORA2A (0.71) ADORA3ADORA2AADORA1ADORA2BSLC6A2
SCHEMBL25098021 0.88 ADORA3 (0.76) ADORA3ADORA2AADORA1TP53CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130045942-A1 N6-SUBSTITUTED ADENOSINE DERIVATIVES AND N6-SUBSTITUTED ADENINE DERIVATIVES AND USES THEREOF INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF MEDICAL SCIENCES (CN) 2013-02-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130045942-A1 N6-SUBSTITUTED ADENOSINE DERIVATIVES AND N6-SUBSTITUTED ADENINE DERIVATIVES AND USES THEREOF ADORA2A, ADORA3, ADORA1 ADORA3 2/4885ADORA2A 1/4885ADORA1 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback